European Journal of Preventive Cardiology

Article	Citations
COP27 Climate Change Conference: urgent action needed for Africa and the world	261
Prime Time for (im) Precision Medicine: From Randomized Clinical Trials to Real-World Evidence	252
Integrating lipoprotein(a) into preventive cardiology: probably important to get the measurement right	204
Anabolic steroids in athletes: the interplay of hormones and inflammation leading to the heart’s vulnerability	179
Validation and comparison of cardiovascular risk prediction equations in Chinese patients with Type 2 diabetes	130
Variations in blood pressure after a 75 g oral glucose load and their implications for detecting hypertension and postprandial hypotension in Chinese adults: a cross-sectional study	107
Increasing pneumococcal vaccination in patients with heart failure: a scalable public health strategy	104
The prevalence and clinical significance of a reduced ventricular ejection fraction in asymptomatic young elite endurance athletes	98
Visceral adiposity, aortic stiffness, and cardiovascular risk	85
Does early initiation of non-statin therapy, evolocumab with LDL-C <50mg/dL contribute to the reduction of hospital readmissions in patients with ACS?: a single center real world evidence from	82
Cardiorespiratory fitness in relation to systolic and diastolic function in patients with heart failure and chronic coronary syndromes	73
Sex specific association of body composition with sphingosine-1-phosphate levels-results from the study of health in pomerania (SHIP) analysis	71
Characteristics and risk of coronary-related events following hospitalisation for chronic coronary disease	70
Type D personality, cardiovascular risk factors and risk of recurrent major adverse cardiac events in outpatients with coronary heart disease	70
Evaluation of the age-related prevalence of cardiovascular risk factors to guide systematic long-term follow-up after preeclampsia	69
Exercise doppler Echocardiography of the right heart and pulmonary circulation in patients with cardiovascular risk factors: observations from the RIGHT Heart International NETwork (RIGHT-NET)	62
Modulation of sympathetic nervous system activity through various therapeutic approaches in patients with resistant hypertension and heart failure with preserved ejection fraction	61
Temporal trends and outcomes of cardiac rehabilitation after acute coronary syndrome in an asian population	61
Statin therapy eligibility in a large primary prevention cohort according to European Society of Cardiology Guidelines	58
Sports-related sudden cardiac arrest: a video analysis of characteristics and outcomes	56
The role of the arrhythmologist in a sports cardiology centre: the devil is in the detail	54
Temporal trends in myocardial infarction case fatality: methodological challenges and prevention targets	54
Secondary prevention of Coronary Heart Disease (CHD) in the Moroccan population. Survey of Risk Factor (SURF) CHD II Morocco	54
Enhancement of left ventricular compliance in twin pregnancy	53
Improvements in walking speed reduce mortality in patients with cardiovascular disease during exercise-based secondary prevention: findings from the ITER registry	52

Treatment of iron deficiency anemia after cardiac surgery	50
Carotid intima-media thickness progression and plaque formation in recreational male endurance athletes - a 10-year follow-up study	49
Genetic variants associated with cardiorespiratory symptoms of long COVID. The GINA-COVID study	49
Association of cardiorespiratory fitness measured by cardiopulmonary exercise testing with covid-19 positivity: a prospective register-based cohort study	48
Effects of a behavioral psychological intervention in addition to an exercise rehabilitation program in chronic heart failure patients	48
Effect of preventive training in cardiac transcriptoma in rats with pulmonary hypertension	47
Baroreflex: ready for prime-time?	46
Social networks as a predictor of cardiovascular disease incidence and mortality: 10-year observation of the Polish HAPIEE cohort	45
Effect of hybrid cardiac rehabilitation using a smart device: a randomized controlled trial	45
Exercise cardiac magnetic resonance imaging in heart failure with preserved ejection fraction	44
Modelling the long-term clinical outcomes of AI-enabled CCTA plaque quantification on preventive cardiovascular management	42
Differences in 10-year cardiovascular risk estimation using SCORE and SCORE2 risk prediction tools: a moderate risk country population analysis	42
Role of Integrated yoga like posture, breathing exercise, music, sattvic diet and bhagwad geeta for quit smoking and cardiovascular prevention as compare to still active smokers	41
An artificial intelligence model to predict 12-month mortality among patients with myocardial infarction	39
Cardiovascular rehabilitation - determinants of long-term outcomes	39
Impact of type D personality on clinical outcomes in Spanish patients with myocardial infarction	39
Effects of inspiratory muscle training on NT-proBNP level, functional exercises capacity and quality of life in patients with cardiac resynchronization therapy: a pilot study	39
Supraventricular tachycardia (SVT) and high troponin levels: patient characteristics and evaluation of coexisting coronary artery disease	39
Women-focused cardiac rehabilitation delivery around the world and program enablers to support broader implementation	38
Safety and efficacy of antiplatelet cessation after transcatheter patent foramen ovale closure	38
Comparison of radial artery occlusion occurrence (RAO) between compression band device and manually applied gauze compression after transradial coronary procedure, a PROBE study	37
Prolonged troponin elevation after high-intensity exercise may indicate coronary artery disease	36
Moderate-to-vigorous physical activity of HFrEF patients is strongly associated with age, but not with functional capacity (6MWT), ejection fraction, NYHA, NT-proBNP, sex or BMI	36
Effect of dapagliflozin on pro-oxidant/antioxidant balance and renal function in patients with diabetic kidney disease to reduce the risk of cardiovascular events	36
Prognostic significance of non-ischemic computational pressure-flow dynamics derived fractional flow reserve in stable coronary artery disease patients in LAD versus non-LAD artery lesions	35
Risk stratification in chronic coronary syndrome: real-world application of SMART and EUROASPIRE scores for treatment optimization	35
Clinical and instrumental follow-up and return to sport after surgical correction of anomalous origin of coronary arteries in young athletes	35
Education training on physical activity in italian medical university courses: a call for action	34
A comprehensive analysis of the impact of high-intensity interval vs. moderate-intensity continuous training on global and regional myocardial function in patients early after acute myocardial infarct	34
Inconsistent association between lipoprotein(a) and coronary artery calcium	33
Heart rate variability and atrial fibrillation in the general population: a longitudinal and mendelian randomization study	33
Cardiovascular health is the essential but overlooked aspect in the management of cancer survivors	32
Factors associated with hospital arrival time of acute stroke patients in rural India	32
LDL-C target attainment in the secondary prevention of atherosclerotic cardiovascular disease in Albania: barriers and strategies to reach the goals	32
The importance of an individualized approach to risk assessment in Fontan patients considering pregnancy	32
Normal echocardiographic and electrocardiographic indices in young female athletes: a meta-analysis across sex, types of sports, races, and ethnicities	31
Cardiovascular risk assessment in male and female patients with and without depression: an electronic health record evaluation in Wales	31
Effect of acetaminophen on blood pressure: a systematic review and meta-analysis of randomized controlled trials	31
Prevalence of ventricular arrhythmias in apparently healthy workers: results from Ferrari Formula Benessere	31
RETRACTED AND REPLACED: Minimal extra-cardiac atherosclerosis present in young people with sudden cardiac death due to coronary artery disease	31
Association of apolipoprotein levels with all-cause and cardiovascular mortality	31
Respiratory vaccines as cardiovascular prevention: evidence from four landmark trials	31
Association of cardiovascular-kidney-metabolic overlap with physical function and prognosis in older patients with heart failure: a post hoc analysis of the FRAGILE-HF and SONIC-HF	31
Gender differences in cardiovascular events among patients with sleep apnoea syndrome: a real-world data analysis of a nationwide epidemiological dataset	30
Nocturnal hypoxaemic burden is associated with incident major adverse cardiovascular events in patients with type 2 diabetes	30
Effect of semaglutide on mortality and cardiovascular events in patients at high cardiovascular risk: an updated systematic review and meta-analysis	29
Human intravenous immunoglobulins for recurrent pericarditis: a multicentre cohort study	29
Early adulthood exercise capacity, but not muscle strength, associates with subclinical atherosclerosis 40 years later in Swedish men	29
Impact of neighbourhood socio-economic status on cardiovascular risk factors in a French urban population	29
Impact of cumulative LDL cholesterol and other risk factors on coronary artery disease prevalence in patients with familial hypercholesterolaemia	29

Flexible addition of risk modifiers on top of SCORE2 to improve long-term risk prediction in healthy individuals	29
Increased cancer incidence in patients with pre-existing heart failure: results from a French nationwide cohort study	29
The relevance of competing risk adjustment in cardiovascular risk prediction models for clinical practice	28
Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry	28
The role of sleep and sleep disorders in the new 2024 European Society of Cardiology guidelines	27
Habitual fish oil supplementation and the risk of incident atrial fibrillation: findings from a large prospective longitudinal cohort study	27
Burden of cardiometabolic disorders and lifetime risk of new-onset atrial fibrillation among men and women: the Rotterdam Study	27
Prognostic value of CT-derived epicardial adipose tissue volume over coronary artery calcium in systemic lupus erythematosus	27
Influence of age and sex on the diagnostic yield of inherited cardiac conditions in sudden arrhythmic death syndrome decedents	27
‘Genetic modelling of triglyceride-rich lipoprotein/remnant lowering mimics APOC3-silencing and predicts clinically relevant coronary heart disease event reductions’: author’s response	27
Body weight and physical fitness in women with ischaemic heart disease: does physical fitness contribute to our understanding of the obesity paradox in women?	26
The Role of Inflammation in Longitudinal Renal Function Decline and Incident Chronic Kidney Disease: The Multi-Ethnic Study of Atherosclerosis	26
A note on base rates and applicability of screeners of psychological disorder in adults with congenital heart disease	26
Bone mineral loss and risk of atrial fibrillation: a multicohort study	26
The association between short-term, chronic localized and chronic widespread pain and risk for cardiovascular disease in the UK Biobank	26
Correction to: Effect of exercise training in patients with chronotropic incompetence and heart failure with preserved ejection fraction: the TRAINING-HR randomized clinical trial	26
Randomized controlled pilot study comparing different digital solutions for the management of hypertensive patients: the HSMonitor-IT study	26
Association between changes in 6-minute walk distance and usual gait speed and prognosis in patients aged 75 years or older with cardiovascular disease	26
Preventing atherosclerosis: rethinking the starting line	26
The ‘environmental exposome’ as a target to reimagine the cardiovascular prevention	26
Intensive blood pressure lowering and the risk of new-onset diabetes in patients with hypertension: a post-hoc analysis of the STEP randomized trial	26
Prognostic value of BMI, NRS2002, and age in predicting in-hospital mortality for acute myocardial infarction: insights from a retrospective analysis	25
Life essential 8 associated with a lower risk of stroke: ideal cardiovascular health in the EPIC-NL prospective cohort study	25
Analysis of the diagnostic value of pre-arrhythmia electrogram storage function of cardiac electronic implantable devices for the diagnosis of cardiac arrhythmias	25
Efficacy and safety of direct oral anticoagulants versus warfarin in obese patients: a systematic review and meta-analysis of 31 studies	25
The adding value of non-invasive assessment of stroke volume during cardiopulmonary exercise testing in hypertrophic cardiomyopathy: beyond O2-pulse	25
Estimating cardiorespiratory fitness in heart failure patients with self-reported questionnaires	24
Cardio-oncological telerehabilitation during and after chemotherapy in breast cancer patients: impact on exercise capacity and quality of life	24
Assessment of heart rate and oxygen consumption during and following a six-minute walk test in patients awaiting liver transplant	24
Endurance training protects the heart during maximal exercise in long-distance runners	24
Lipoprotein(a) and referrals to a specialist lipid clinic	24
Exercise-based cardiac rehabilitation for patients with atrial fibrillation receiving catheter ablation: associations with long-term clinical outcomes	24
Temporal trends over 20 years of smoking prevalence in patients with acute myocardial infarction. Data from the RICO survey	24
Socioeconomic status and recurrent cardiovascular events: preventing the worst or striving for the best?	24
Vascular retinopathy and relationship with long-term development of ischemic heart disease. Results of the RETICARD registry	24
Association of 10-year blood pressure trajectory with calcification volume in different vessel beds	23
Psychosocial outcomes after a home cardiac rehabilitation program	23
Exercise and phenotypic progression in arrhythmogenic cardiomyopathy	23
Comprehensive cardiac rehabilitation in elderly patients with heart failure: age is just a number?	23
Balancing methodological rigour and clinical relevance in lipid variability research	23
Chronotropic index, heart rate and exercise capacity in diabetes mellitus: comparing two different high-intensity interval training protocols	23
Impact of cardiac rehabilitation on functional capacity and body composition across the heart failure spectrum	22
Chemosensitivity and its association with exercise ventilation inefficiency in patients with chronic coronary syndromes compared to heart failure	22
Association of right and left atrial strain with laboratory, anthropometric and echocardiographic markers - the influence of COVID-19 pandemic	22
Genetic risk disclosure and behavioural change: not so fast	22
Optimising screening of intermediate to high-risk asymptomatic sportsmen with exercise electrocardiogram. The SEEPRED study	22
Physical activity and autonomic function in patients with heart failure: a mediation analysis of functional exercise capacity	22
Low prevalence of cardiac abnormalities in competitive athletes before the return-to-play after COVID-19 based on the italian strategy	22
Comparative effectiveness of pharmacologic agents for heart failure prevention in post-myocardial infarction patients: A comprehensive Bayesian network meta-analysis	22
Characteristics of women attending a phase 3 cardiovascular rehabilitation program: is there a need for a more tailored intervention?	22
Diagnosis first: assessing kidney function in cardiovascular rehabilitation patients	22
STELA (systematic technology for enhanced longevity and atherosclerosis prevention): development and initial implementation of a novel platform for population-based primary cardiovascular prevention	21
Navigating omega-3s	21
Do triglycerides impact cardiovascular outcomes? A 10-year follow up study from a Portuguese cohort	21
Association between high occupational physical workload and ischaemic heart disease, and the influence of cardiorespiratory fitness in 284 436 Swedish men	21
The influence of triglyceride and low-density-lipoprotein target levels on microcirculation	21
Role of telecardiology in prevent mortality and improve quality of life in patients with chronic heart failure : a meta-analysis of randomized controlled trials	21
When the smoke clears: the enduring threat of tobacco in stable coronary artery disease	21
Coronary artery calcium score in the young: is it time to update the guidelines?	20
The influence of exercise and postural changes on ventricular repolarization in the long QT syndrome: a systematic scoping review	20
Editorial comments: Focus on cardiovascular risk screening	20
Influenza vaccination: a call for cardiologists	20
Hypnotic use and the risk of cardiovascular diseases in insomnia patients	20
Editorial comments: focus on cardiovascular risk in type 2 diabetes mellitus and metabolic disorders	20
To prevent hypertension in Africans: do we need to eat more vegetables?	20
Unveiling the gender divide in heart failure prognosis: new insights from a comprehensive meta-analysis	20
Sex-specific time trends in incident atrial fibrillation and the contribution of risk factors: the Tromsø Study 1994–2016	20
Is our destiny written in our genes? A sentence or an opportunity to prevent cardiovascular diseases?	20
High blood pressure puts a high pressure in low- and middle-income countries	20
Comment on ‘Anabolic–androgenic steroids and cardiac function’	19
Exercise training and regression of coronary atheromatous plaques	19
The positive impact of the Life's Essential 8 in the prevention of incident heart failure	19
Battle between high-intensity interval training and moderate-intensity continuous training in cardiac rehabilitation practice	19
Genetically predicted adipose tissue distribution influences the risk of atherosclerosis	19
Is it time to get SIRIUS aboutin silicomodelling of cardiovascular outcomes trials?	19
A forward-looking approach in women living with the Fontan circulation: from cardio-obstetric to cardio-reproductive medicine	19
Validation of the LIFE-CVD2 model for lifetime cardiovascular risk prediction in cancer survivors	19
Hyper-trabeculation in olympic athletes: advanced LV function analysis by CMR	18
Novel echocardiographic measures of myocardial work predicts physical performance during prolonged strenuous exercise	18
Echocardiographic findings in COVID: incidence of carditis and correlations with COVID variants	18

Can we prevent cardiac conduction disease?	18
Lipoprotein(a) and new-onset atrial fibrillation: where does the evidence lead us?	18
The impact of cardiac SPECT in risk stratification for women with suspected coronary artery disease in a very high cardiovascular risk country	18
The validity and reliability of the 6 minute stepper test in patients with systemic hypertension	18
Association and predictive value of immunoglobulin and complement levels for incident coronary heart disease: a nested case-control study in Chinese adults	17
Critical review of the studies identifying determinants of a change in fitness following a cardiac rehabilitation outpatient programme	17
Meditation as a stress management strategy in cardiac rehabilitation for coronary artery disease patients: a randomized controlled trial	17
Arrhythmic prevalence during Harvard Step Test and Maximal Exercise Test in young athletes: a comparative analysis	17
Improved adherence to guideline-recommended treatments in a specialist preventative pharmacology clinic compared to standard cardiology clinics after an acute coronary syndrome	17
Traditional versus extended hybrid cardiac rehabilitation based on the continuous care model for coronary artery bypass surgery patients in a middle-income country: an embedded mixed method	17
Identifying lifestyle patterns and awareness of cardiovascular disease among women in lombardy-italy: insights from the a call for women project	17
Exercise hemodynamics and metabolisms in (very) sportive patients after orthotopic heart transplantation	17
Life’s essential 8 and progression of cardiometabolic multimorbidity trajectory: a prospective study of UK biobank	17
Usefulness of impedanciometry for the assessment of obesity in a high risk dyslipidemia screening unit	17
Does evolocumab treatment reduce carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia?: Reply	17
Extension of heterozygous familial hypercholesterolaemia treatment recommendations by including both low-density lipoprotein and lipoprotein(a) burden: a unique opportunity to improve patient prognosi	17
Exercise oscillatory breathing in heart failure with reduced ejection fraction: clinical implication	17
Association of genetically predicted problem alcohol use with risk of atrial fibrillation: a Mendelian randomization study	17
Characterization and natural history of different phenotypes in hereditary transthyretin amyloidosis: 40-year experience at a single Italian referral centre	17
Endothelin-1 negatively correlates with functional capacity in patients with breast cancer receiving first line anthracycline-based chemotherapy	17
Severe dyslipidemia title: known by patients, but is it treated?	17
Sex-specific temporal trends in the incidence and prevalence of cardiovascular disease in young adults: a population-based study using UK primary care data	16
Comment on ‘Severe obesity in patients with ST-elevation myocardial infarctions: association with age, temporal trends, and clinical outcomes’	16
Aspirin and lipoprotein(a): lessons from replication at scale	16
Combining European and U.S. risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study	16
Smoking timing, genetic susceptibility, and the risk of incident atrial fibrillation: a large prospective cohort study	16
Apolipoprotein B outperforms low density lipoprotein particle number as a marker of cardiovascular risk in the UK Biobank	16
Making a quality diagnosis of familial hypercholesterolaemia in children	16
Association of nt-probnp and left ventricular ejection fraction and their utility as predictors of in-hospital mortality among heart failure patients admitted in a tertiary hospital in davao city	16
Apparent treatment-resistant hypertension associated lifetime cardiovascular risk in a longitudinal national registry	16
Acute myocardial infarction triggered by physical exertion: a systematic review and meta-analysis	16
Effects of endurance exercise training on left ventricular structure in healthy adults: a systematic review and meta-analysis	16
Long-term prognosis of unrecognized myocardial infarction in women and men from the general population: the Rotterdam Study	16
Association of endogenous oxidants and antioxidants with risk of atherosclerotic cardiovascular disease	16
Exposure to ultra-processed food and risk of cardiovascular mortality: a prospective cohort study	16
Predictive improvement of adding coronary calcium score and a genetic risk score to a traditional risk model for cardiovascular event prediction	16
Left atrial dysfunction predicts left ventricular remodelling in patients with preserved ejection fraction after acute ST-elevation myocardial infarction	16
Obesity and cardiovascular health	15
Cumulative remnant cholesterol predicts cardiovascular outcomes in elderly patients with atherosclerotic cardiovascular disease	15
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association	15
Accelerometer-measured circadian alignment predicts all-cause and cardiovascular mortality in middle-aged and older adults	15
Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromes	15
Increased nation-wide uptake after establishment of comprehensive outpatient cardiac centres in Slovenia: an interrupted time-series	15
Overview of Cardiac Rehabilitation following post-acute myocardial infarction in European Society of Cardiology member countries	15
Trends in cardiovascular mortality in the United States from 1968 to 2019: analysis of the CDC WONDER database	15
Life’s Essential 8 and the risk of cardiovascular disease death and all-cause mortality in Finnish men	15
The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis	15
The impact of BMI into the ESC SCORE2 model on cardiovascular risk reclassification: results from a 20-year cohort study	15
Does the length of evolocumab use contribute to myocardial infarction associated hospital readmissions in patients with ACS?: a single center real world evidence from ELAINE	15
Congenital heart disease: changes in recorded birth prevalence and cardiac interventions over the past half-century in Sweden	15
Atrial fibrillation in female endurance athletes	15
Exercise intensity and cardiac disease development in carriers of titin variants	15
Cardiovascular disease and mental health: a dangerous duo?	15
Combining the systematic coronary risk evaluation (SCORE2-SCORE2-OP) with anthropometric measures to refine 10-year cardiovascular prediction in a population-based cohort study	15
Increased cardiometabolic index is associated with impaired exercise capacity and heart failure with preserved ejection fraction in old hypertensives	14
Physical functioning predicts cognition in systolic heart failure	14
Different isometric exercise modalities induce divergent acute effects on myocardial work efficiency in hypertensive patients with coronary heart disease	14
Decline of physical performance in patients with transthyretin amyloid cardiomyopathy assessed by cardiopulmonary exercise testing	14
Cardiovascular pathologies in post-covid syndrome	14
Changes in physical activity levels following different exercise modalities in patients with atrial fibrillation: a 1-year follow-up	14
Effect of sodium-glucose cotransporter-2 inhibitors on kidney outcomes of individuals with type 2 diabetes according to blood pressure levels	14
The role of electrocardiographic findings in pulmonary embolism risk assessment	14
Effects of the addition of high- vs. low-intensity resistance training on top of endurance training in patients with heart failure: preliminary results from a randomized clinical trial	14
Cardiac rehabilitation can change the destiny of the patient with ST-elevation acute coronary syndrome	14
Environmental noise exposure and prognosis after an acute myocardial infarction: findings from ENVI-MI study	14
Comparison of inpatient and outpatient cardiac rehabilitation following myocardial infarction	14
Anticoagulation of post-operative atrial fibrillation during cardiac rehabilitation	14
Intervention is needed in polycystic ovary syndrome for prevention of cardiovascular diseases	14
Predictive value of HCO3- on the no-reflow phenomenon in STEMI patients	14
Chronic adaptations to exercise in thin-walled chambers of the heart: a longitudinal study echocardiographic study of elite athletes	14
SGLT2i effects depending on functional capacity in ATTR-CM	13
Overall benefits of smoking cessation in patients with ASCVD are underestimated	13
Tailored interventions to improve adherence to antihypertensive treatment and reduce blood pressure: findings from a systematic review and meta-analysis	13
Apolipoprotein B and cardiovascular risk in asymptomatic patients: need for systematic evaluation?	13
Different patterns of lifestyles, sociodemography, clinical patterns, and cardiovascular health awareness among women: results from the ‘Call for Women’ population-based survey	13
Analysis of an acute effect of air pollution on cardiovascular mortality in Eastern Poland (EP-PARTICLES study)	13
The effect of lifestyle and risk factor modification on occlusive peripheral arterial disease outcomes: standard healthcare vs structured programme: a pilot randomised controlled study	13
Sudden cardiac arrest and role of sport preparticipation screening in children	13
Atrial fibrillation progression and burden after the first clinical episode: a prospective observational study via implantable loop recorders	13
Statin therapy in chronic heart failure with reduced ejection fraction: a post-hoc analysis of T.O.S.C.A. Registry	13
Genetic risk score for risk stratification of patients positive for SARS-CoV-2 virus. The CARGENCORS study	13
Doctor-patient communication about personal cardiovascular risk: a missing piece of the prevention puzzle?	13
Adding parenteral anticoagulation in STEMI undergoing PCI: safety and efficacy?	13
Lipoprotein(a), are its levels really invariable?	13
Feasibility of an exercise-based cardiac telerehabilitation program for patients with ischemic heart disease: a pilot study	13
Predictive value of both irisin and apelin for heart failure with preserved ejection fraction in type 2 diabetes mellitus patients	13
A big data-driven eHealth approach to prevent, detect, and reduce atherosclerotic cardiovascular disease burden	13
Insomnia in patients with myocardial infarction with and without obstructive coronary arteries: prevalence and prognosis	13
Psychological factors beyond the SMART2 model for predicting recurrent events in atherosclerotic cardiovascular disease patients	13
Inequalities in the provision of guideline-directed medical therapy following myocardial infarction	13
Associations of anthropometric markers with arterio-venous ratio in the general population	13
Impact of phase ii exercise-based cardiac rehabilitation on HDL-c levels and the predictive role of systemic inflammatory index in patients with coronary artery disease	13
Longitudinal insights into coronary plaque amongst master athletes	13
Cardiovascular risk in multiple sclerosis: exploring the role of vitamin D - insights from the Cardio-MS project	13
Haptoglobin levels: an emerging biomarker or a bystander?	12